Nima Sharifi MD
@nimasharifimd.bsky.social
980 followers 830 following 170 posts
Scientific Director Desai Sethi Urology Institute Sylvester Comprehensive Cancer Center University of Miami Miller School of Medicine https://www.nimasharifilab.com
Posts Media Videos Starter Packs
nimasharifimd.bsky.social
"Rockets, computers and lifesaving medicines all come from decades of effort by scientists hunkered over pages of calculation or the laboratory bench. They required the same tireless, single-minded effort every elite athlete understands." 🧪 @adamfrank4.bsky.social www.nytimes.com/2025/10/03/o...
Opinion | How the Manosphere Hijacks Young Men’s Interest in Science
www.nytimes.com
Reposted by Nima Sharifi MD
scifri.bsky.social
Today, scientists know that genetics plays a role in many conditions and diseases. But back in the ’90s, geneticist Mary-Claire King was the first to link a gene to an inherited form of a common cancer.
A Trailblazing Geneticist Reflects On Her Life And Work
Dr. Mary-Claire King was the first to link a gene to hereditary cancer risk with the identification of BRCA1. She was just getting started.
buff.ly
nimasharifimd.bsky.social
These pelicans out this morning are just magnificent and mesmerizing to watch
nimasharifimd.bsky.social
Congratulations @marinaparry.bsky.social! Wonderful work!
marinaparry.bsky.social
REALLY thrilled to share findings from my postdoc work in the Attard lab, which form part of this www.sciencedirect.com/science/arti....

Thanks to Emily and Gert for seeing it over the line, all the funders, the Veracyte, MRC CTU & STAMPEDE teams, and patients who contributed samples. Pls share!
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers
Advanced prostate cancers respond to hormone therapy but outcomes vary and no predictive tests exist for informed treatment selection. To identify nov…
www.sciencedirect.com
nimasharifimd.bsky.social
Enjoyed working with Masoud Bitaraf and Elena Castro on this review on prostate cancer germline variants with therapeutic implications for Trends in Molecular Medicine! 🧪 #UroSky #MedSky @cp-trendsmolecmed.bsky.social authors.elsevier.com/a/1lWYz5Eb1B...
authors.elsevier.com
nimasharifimd.bsky.social
Congrats to you and your team, Ralph! @rjdlab.bsky.social
nimasharifimd.bsky.social
I consider myself fortunate for every day I can continue to do science
nimasharifimd.bsky.social
An Editor's Pick paper at J Biol Chem @asbmb.bsky.social! Don't forget to read the profile about the first author Xiuxiu Li at the end of our paper on HSD3B1 and breast cancer! Dr. Li recently moved from University of Miami to the University of Alabama! 🧪 www.sciencedirect.com/science/arti...
Reposted by Nima Sharifi MD
nimasharifimd.bsky.social
Sage advice as always from @rjdlab.bsky.social 🧪
rjdlab.bsky.social
Thanks Nature Cancer for the chance to reflect on some factors that led me to study cancer metabolism. For the trainees and other young scientists: the critical events that shape your career might not be obvious while they are happening. Keep an open mind and trust your instincts.

rdcu.be/evi4I
An unexpected career in cancer metabolism
Nature Cancer - Ralph DeBerardinis obtained an MD and PhD from the University of Pennsylvania, then trained in Pediatrics and Medical Genetics at Children’s Hospital of Philadelphia. He moved...
rdcu.be
nimasharifimd.bsky.social
I love coming across these majestic creatures! #pelicans
nimasharifimd.bsky.social
Congrats Zhenfei Li and his team on his story @pnas.org on fine structural design of 3βHSD1 inhibitors for prostate cancer therapy! His work builds on many years of work on HSD3B1 genetics and metabolism in prostate cancer! @pcf-science.bsky.social 🧪https://www.pnas.org/doi/10.1073/pnas.2422267122
Fine structural design of 3βHSD1 inhibitors for prostate cancer therapy | PNAS
Prostate cancer is a global health challenge, particularly for patients resistant to the second-generation anti-androgen receptor pathway inhibitor...
www.pnas.org
nimasharifimd.bsky.social
So proud of @charles-dai.bsky.social who just landed a Damon Runyon Physician-Scientist Award! Charlie was previously an HHMI med fellow in our group. He truly has all the "right stuff" as he is becoming a leading investigator in breast and prostate cancers! 🧪 www.damonrunyon.org/news/entries...
Damon Runyon Cancer Research Foundation invests nearly $1.4 million to support physician-scientists
www.damonrunyon.org